BRD4 and neoplasm: Furthermore, it induced rapid tumor regression (>90%) in RS4;11 xenograft tumors, without significant adverse effects in mice, with a single administration capable of causing complete degradation of BRD4 for more than a day, with induction of cell apoptosis.129